Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vaxcyte Inc shares valued at $686,518 were sold by GUGGENHIME ANDREW on Nov 18 ’24. At $85.81 per share, GUGGENHIME ANDREW sold 8,000 shares. The insider’s holdings dropped to 109,491 shares worth approximately $9.41 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GUGGENHIME ANDREW purchased 8,000 shares, netting a total of over 692,000 in proceeds.
Before that, PICKERING GRANT had sold 2,366 shares from its account. In a trade valued at $245,796, the CHIEF EXECUTIVE OFFICER traded Vaxcyte Inc shares for $103.89 each. Upon closing the transaction, the insider’s holdings decreased to 2,366 shares, worth approximately $11.81 million.
As published in their initiating research note from Mizuho on December 07, 2023, Vaxcyte Inc [PCVX] has been a Buy and the price target has been revised to $69. Analysts at TD Cowen started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid April. As of January 03, 2023, Needham has reiterated its “Buy” rating for PCVX. Earlier on December 15, 2022, Guggenheim initiated its rating. Their recommendation was “a Buy” for PCVX stock.
Analyzing PCVX Stock Performance
During the last five days, there has been a drop of approximately -11.04%. Over the course of the year, Vaxcyte Inc shares have jumped approximately 36.88%. Shares of the company reached a 52-week high of $121.06 on 09/19/24 and a 52-week low of $53.83 on 01/05/24. A 50-day SMA is recorded $108.95, while a 200-day SMA reached $83.06. Nevertheless, trading volume fell to 1.71 million shares from 2.01 million shares the previous day.
Support And Resistance Levels for Vaxcyte Inc (PCVX)
According to the 24-hour chart, there is a support level at 84.74, which, if violated, would cause prices to drop to 83.52. In the upper region, resistance lies at 87.62. The next price resistance is at 89.29. RSI (Relative Strength Index) is 22.90 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -11.59, which suggests the price will decrease in the coming days. Percent R is at 95.43%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
